Title : The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer.

Pub. Date : 2021 Apr

PMID : 33647599






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer. Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate of trastuzumab [a monoclonal antibody against human epidermal growth factor receptor 2 (HER2)] and DM1 (an inhibitor of tubulin polymerisation). Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate of trastuzumab [a monoclonal antibody against human epidermal growth factor receptor 2 (HER2)] and DM1 (an inhibitor of tubulin polymerisation). Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens